TEMPO.CO, Jakarta – The Indonesian Ministry of Health said it still has a budget of IDR 1.3 trillion allocated for the procurement of COVID-19 vaccines produced in the country this year.
“To be frank, the budget for the purchase of national vaccines is still available for 2022. We will use IDR 1.3 trillion,” Deputy Health Minister Dante Saksono Harbuwono told a press conference. virtual launch of the phase 3 vaccine clinical trial on Thursday, June 9, 2022.
According to Dante, COVID-19 vaccination coverage in Indonesia is already high, reaching over 400 million injections. “But we don’t know when the pandemic will be over.”
Dante added that the current pandemic situation is under control, proven by the low number of deaths, transmission rate, hospital occupancy rate and vaccination rate.
It was also supported by the results of a serological survey which aims to measure the antibody of the Indonesian people to the risk of transmission of SAR-CoV-2 which is currently high or around 99.2%.
Although there is a significant drop in the number of positive cases, the government has no idea when public immunity will drop. Dante said the Department of Health will assess the public’s need for the COVID-19 vaccine. “After [ensuring that] domestic need [is fulfilled]state enterprises will export vaccines to countries that need them,” he said.
Click on here at obtain the last new updates of Time in Google New